On the stock market since 2024, it operates in the world of health and science. It has 14,605 employees. Now — the numbers.
The stock trades 51% below its peak. The market has trimmed its expectations for the company.
Over the last 12 months, company executives reported 2 buys and 0 sells. Management buying with its own money is usually read as a good sign.
The average analyst price target is $11.92 — 127% above today’s price.
Since the drop from its peak, buyer appetite hasn’t come back.
On our five-subject report card, AUNA sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.
The takeaway: AUNA is a high-risk stock — not yet profitable, and its future rides on its product catching on.